Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Bone Diseases × Pamidronate × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 5 Multiple Myeloma 3 Neoplasms, Plasma Cell 2 Neoplasm Metastasis 2 Spondylitis, Ankylosing 1 Pain 1 Bone Diseases 1

Interventions

Zoledronic Acid 3 Denosumab 3 radium Ra 223 dichloride 1 odanacatib 1 etelcalcetide hydrochloride 1 cabozantinib 1 Standard of Care 1 Pamidronate 1 Paclitaxel 1 Exercise 1 Bone Marrow Transplantation 1 BHQ880 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02101164 2015-02-18

Evaluate Time Associated With the Preparation & Administration of Denosumab/Pamidronate in Patients With Solid Tumors and Metastatic Bone Disease

Amgen

Phase 4 Withdrawn

Bone Diseases

Data powered by HemOnc (CC BY 4.0) Colophon ⚡